|Bid||0.00 x 800|
|Ask||0.00 x 800|
|Day's Range||23.26 - 24.72|
|52 Week Range||21.46 - 59.67|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Mar 09, 2022 - Mar 14, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||43.76|
Subscribe to Yahoo Finance Plus to view Fair Value for GDRXLearn more
Investment company Boothe Investment Group, Inc. (Current Portfolio) buys JPMorgan BetaBuilders Japan ETF, GoodRx Holdings Inc, Li-Cycle Holdings Corp, UiPath Inc, Sunrun Inc, sells Vanguard Short-Term Bond ETF, MP Materials Corp, Xilinx Inc, iShares MSCI Emerging Markets ETF during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Boothe Investment Group, Inc..
DermTech (NASDAQ: DMTK) and GoodRx (NASDAQ: GDRX) have been huge losers for investors over the last 12 months. In this Motley Fool Live video, recorded on Jan. 12., Fool contributors Keith Speights and Brian Orelli answer a viewer's question about whether or not it's time to sell these beaten-down healthcare stocks. Brian Orelli: I don't really follow GoodRx all that closely, so maybe you can comment on that one if you do.
Investment company Transcend Wealth Collective, Llc (Current Portfolio) buys Alerian MLP ETF, ITT Inc, iShares Interest Rate Hedged Corporate Bond ETF, Intel Corp, iShares Global Consumer Staples ETF, sells Intercontinental Exchange Inc, Quadratic Interest Rate Volatility And Inflation H, iShares MSCI All Country Asia ex Japan Index Fund, iShares Latin America 40 ETF, Peloton Interactive Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Transce